GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » 180 Degree Capital Corp (NAS:TURN) » Definitions » Quality Rank

180 Degree Capital (180 Degree Capital) Quality Rank


View and export this data going back to 1992. Start your Free Trial

What is 180 Degree Capital Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

180 Degree Capital Quality Rank Related Terms

Thank you for viewing the detailed overview of 180 Degree Capital's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

180 Degree Capital (180 Degree Capital) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » 180 Degree Capital Corp (NAS:TURN) » Definitions » Quality Rank
Comparable Companies
ENDI GRF PIAC CUBA RAND GROW EGF PYN NXN MFV BLK BX KKR OSTO:INVE A APO TSX:BN BK AMP LSE:III XSWX:PGHN
Traded in Other Exchanges
N/A
Address
7 N. Willow Street, Suite 4B, Montclair, NJ, USA, 07042
Website
http://www.180degreecapital.com
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
Executives
Kevin Rendino director 800 SCUDDERS MILL RD, PLAINSBORO NJ 08536
Daniel B Wolfe officer: Vice President HARRIS & HARRIS GROUP, 111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Bigelow Robert E Iii officer: VP, Head of Fund Development 7 NORTH WILLOW STREET SUITE 4B, MONTCLAIR NJ 07042
Alicia M Gift officer: Treasurer, Secretary 1450 BROADWAY, 24TH FLOOR, NEW YORK NY 10018
Richard P Shanley director 111 WEST 57TH STREET, NEW YORK NY 10019
Tonia L Pankopf director 8 SOUND SHORE DR STE 215, GREENWICH CT 06830
Parker Anders Weil director 262 MCKINLEY PLACE, RIDGEWOOD NJ 07450
Stacy Brandom director 1450 BROADWAY, NEW YORK NY 10018
Robert Stephen Burns officer: Senior Vice President 1450 BROADWAY, NEW YORK NY 10018
Bruce W Shewmaker director 12 BRIAR WOOD DRIVE, SHORT HILLS NJ 07078
Lucio Lanza director 141 CASPIAN COURT, SUNNYVALE CA 94089
Misti Ushio officer: Vice President 111 WEST 57TH STREET, NEW YORK NY 10019
Charles E Ramsey director 111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Ayres W Dillaway Jr director 111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Michael A Janse officer: Executive Vice President 111 WEST 57TH STREET SUITE 1100, NEW YORK NY 10019